Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (381) 381
life sciences & biomedicine (369) 369
humans (337) 337
female (310) 310
pathology (238) 238
immunohistochemistry (158) 158
middle aged (145) 145
oncology (129) 129
tumors (121) 121
aged (120) 120
ovarian neoplasms - pathology (112) 112
adult (110) 110
biological and medical sciences (106) 106
medical sciences (100) 100
obstetrics & gynecology (96) 96
ovarian cancer (96) 96
cancer (94) 94
prognosis (83) 83
ovarian neoplasms - genetics (79) 79
mutation (72) 72
gynecology. andrology. obstetrics (62) 62
aged, 80 and over (61) 61
biomarkers, tumor - analysis (56) 56
neoplasm staging (54) 54
surgery (49) 49
carcinoma (47) 47
endometrial neoplasms - pathology (46) 46
ovarian neoplasms - metabolism (46) 46
biomarkers, tumor - metabolism (45) 45
cell biology (45) 45
female genital diseases (45) 45
endometrial cancer (43) 43
abridged index medicus (42) 42
cystadenocarcinoma, serous - pathology (42) 42
tissue array analysis (41) 41
ovarian carcinoma (40) 40
analysis (37) 37
investigative techniques, diagnostic techniques (37) 37
carcinoma, endometrioid - pathology (36) 36
genetic aspects (36) 36
pathology. cytology. biochemistry. spectrometry. miscellaneous investigative techniques (35) 35
diagnosis (34) 34
neoplasm grading (34) 34
research (34) 34
animals (31) 31
breast cancer (31) 31
ovarian neoplasms - diagnosis (31) 31
ovary (31) 31
kaplan-meier estimate (30) 30
biomarkers, tumor - genetics (29) 29
reproducibility of results (29) 29
breast neoplasms - pathology (27) 27
cohort studies (27) 27
gene expression regulation, neoplastic (27) 27
dna mutational analysis (26) 26
endometrial neoplasms - genetics (26) 26
endometrium (26) 26
gene expression (26) 26
retrospective studies (26) 26
carcinoma - pathology (25) 25
male (25) 25
obstetrics and gynecology (25) 25
care and treatment (24) 24
diagnosis, differential (24) 24
disease-free survival (24) 24
risk factors (24) 24
cell line, tumor (23) 23
cystadenocarcinoma, serous - genetics (22) 22
endometrial carcinoma (22) 22
hematology, oncology and palliative medicine (22) 22
chemotherapy (21) 21
medical research (21) 21
ovarian neoplasms - mortality (21) 21
adenocarcinoma, clear cell - pathology (20) 20
breast neoplasms - metabolism (20) 20
canada (20) 20
endometrial neoplasms - metabolism (20) 20
ovarian neoplasms - chemistry (20) 20
p53 (20) 20
predictive value of tests (20) 20
survival analysis (20) 20
carcinoma, endometrioid - genetics (19) 19
endocrine system diseases (19) 19
mice (19) 19
research article (19) 19
treatment outcome (19) 19
health aspects (18) 18
in situ hybridization, fluorescence (18) 18
nuclear proteins - genetics (18) 18
ovarian neoplasms - drug therapy (18) 18
fallopian tube neoplasms - pathology (17) 17
gene expression profiling (17) 17
gynecology (17) 17
p53 protein (17) 17
proteins (17) 17
tumor proteins (17) 17
young adult (17) 17
biomarkers (16) 16
breast neoplasms - genetics (16) 16
high-grade serous carcinoma (16) 16
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Ovarian carcinoma pathology and genetics: recent advances
by Gilks, C. Blake, MD and Prat, Jaime, MD
Human pathology, ISSN 0046-8177, 2009, Volume 40, Issue 9, pp. 1213 - 1223
Pathology | Clear cell | Tumor cell type | Mucinous | Ovarian surface epithelial carcinoma | Endometrioid | Serous | Ovarian cancer | Life Sciences & Biomedicine | Science & Technology | Gynecology. Andrology. Obstetrics | Investigative techniques, diagnostic techniques (general aspects) | Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques | Biological and medical sciences | Medical sciences | Female genital diseases | Tumors | Immunohistochemistry | Ovarian Neoplasms - classification | Diagnosis, Differential | Ovarian Neoplasms - diagnosis | Humans | Ovarian Neoplasms - pathology | Carcinoma - diagnosis | Female | Genetic Techniques - trends | Carcinoma - classification | Carcinoma - pathology | Genetic aspects | Carcinoma | Cancer | Proteins | Chemotherapy | Genetics | Mutation | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Confirmation of ProMisE: A simple, genomics‐based clinical classifier for endometrial cancer
by Talhouk, Aline and McConechy, Melissa K and Leung, Samuel and Yang, Winnie and Lum, Amy and Senz, Janine and Boyd, Niki and Pike, Judith and Anglesio, Michael and Kwon, Janice S and Karnezis, Anthony N and Huntsman, David G and Gilks, C. Blake and McAlpine, Jessica N
Cancer, ISSN 0008-543X, 03/2017, Volume 123, Issue 5, pp. 802 - 813
prognostic | risk‐stratification system | mismatch repair | endometrial carcinoma | histotype | polymerase‐ɛ (POLE) | The Cancer Genome Atlas (TCGA) | p53 | polymerase-ɛ (POLE) | risk-stratification system | Life Sciences & Biomedicine | Oncology | Science & Technology | Microsatellite Instability | Endometrial Neoplasms - classification | Humans | Risk Factors | Mutation, Missense | DNA Mismatch Repair - genetics | Tumor Suppressor Protein p53 - genetics | Disease-Free Survival | Poly-ADP-Ribose Binding Proteins | Endometrial Neoplasms - genetics | Adult | Endometrial Neoplasms - pathology | Female | Aged | Biomarkers, Tumor - genetics | Mutation | Neoplasm Staging | DNA Polymerase II - genetics | Pathology, Molecular | Clinical trials | Usage | Diagnosis | Endometrial cancer | Risk factors | Colorectal cancer | Immunohistochemistry | Classifiers | Prognosis | Carcinoma | p53 Protein | Genomics | Genomes | Subgroups | Proteins | Exonuclease | Missense mutation | Mismatch repair | Classification | Endometrium | Medical research | Risk groups | Feasibility studies | Health risks | Risk analysis | Survival | Polymerase | Medical prognosis | Risk management | Tumors | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text The disparate origins of ovarian cancers: Pathogenesis and prevention strategies
by Karnezis, Anthony N and Cho, Kathleen R and Gilks, C. Blake and Pearce, Celeste Leigh and Huntsman, David G
Nature reviews. Cancer, ISSN 1474-175X, 01/2017, Volume 17, Issue 1, pp. 65 - 74
Life Sciences & Biomedicine | Oncology | Science & Technology | Ovarian Neoplasms - prevention & control | Humans | Ovarian Neoplasms - pathology | Ovarian Neoplasms - physiopathology | Female | Tumor Microenvironment - physiology | Ovarian Neoplasms - etiology | Prevention | Transcription factors | Analysis | Germ cell tumors | Endometriosis | Research | Risk factors | Ovarian cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Rare cancers: a sea of opportunity
by Boyd, Niki, PhD and Dancey, Janet E, Prof and Gilks, C Blake, Prof and Huntsman, David G, Prof
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 2, pp. e52 - e61
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Rare Diseases - genetics | Neoplasms - therapy | Rare Diseases - therapy | Neoplasms - genetics | Genomics | Humans | Immunotherapy | Neoplasms - classification | Rare Diseases - pathology | Mutation | Molecular Targeted Therapy | Neoplasms - pathology | Cell differentiation | Developmental biology | Epidemiology | Analysis | Cancer | Medical research | Medicine, Experimental | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention
by McAlpine, Jessica N., MD and Hanley, Gillian E., MA, PhD and Woo, Michelle M.M., PhD and Tone, Alicia A., PhD and Rozenberg, Nirit and Swenerton, Kenneth D., MD and Gilks, C. Blake, MD and Finlayson, Sarah J., MD and Huntsman, David G., MD and Miller, Dianne M., MD and Ovarian Cancer Research Program of British Columbia and Ovarian Canc Res Program British
American journal of obstetrics and gynecology, ISSN 0002-9378, 2014, Volume 210, Issue 5, pp. 471.e1 - 471.e11
Obstetrics and Gynecology | educational campaign | ovarian cancer | salpingectomy | safety | prevention | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Education, Medical, Continuing | Salpingectomy - statistics & numerical data | Ovarian Neoplasms - prevention & control | Humans | Ovarian Neoplasms - physiopathology | Fallopian Tubes - physiopathology | British Columbia | Sterilization, Tubal | Gynecology - education | Operative Time | Young Adult | Adolescent | Adult | Female | Retrospective Studies | Hysterectomy - statistics & numerical data | Odds Ratio | Prevention | Complications and side effects | Ovarian cancer | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Vulval squamous cell carcinoma and its precursors
by Singh, Naveena and Gilks, C Blake
Histopathology, ISSN 0309-0167, 01/2020, Volume 76, Issue 1, pp. 128 - 138
DEVIL | VAAD | dVIN | VIN | vulva | HSIL | squamous cell carcinoma | Pathology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Squamous cell carcinoma | Human papillomavirus | Tumorigenesis | Lesions | Cervix | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma
by Gilks, C. Blake, MD and Ionescu, Diana N., MD and Kalloger, Steve E., BSC and Köbel, Martin, MD and Irving, Julie, MD and Clarke, Blaise, MD and Santos, Jennifer, RN and Le, Nhu, PhD and Moravan, Veronika and Swenerton, Kenneth, MD and on behalf of the Cheryl Brown Ovarian Cancer Outcomes Unit of the British Columbia Cancer Agency, Vancouver, BC and British Columbia Canc Agcy and Cheryl Brown Ovarian Cancer Outcomes Unit of the British Columbia Cancer Agency
Human pathology, ISSN 0046-8177, 2008, Volume 39, Issue 8, pp. 1239 - 1251
Pathology | Grade | Prognosis | Cell type | Ovarian cancer | Life Sciences & Biomedicine | Science & Technology | Gynecology. Andrology. Obstetrics | Investigative techniques, diagnostic techniques (general aspects) | Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques | Biological and medical sciences | Medical sciences | Female genital diseases | Tumors | Immunohistochemistry | WT1 Proteins - analysis | Ovarian Neoplasms - chemistry | Reproducibility of Results | Carcinoma - surgery | Humans | Middle Aged | Ovarian Neoplasms - pathology | Carcinoma - chemistry | Disease-Free Survival | Ovarian Neoplasms - classification | Female | Aged | Carcinoma - classification | Carcinoma - pathology | Observer Variation | Ovarian Neoplasms - surgery | Chemotherapy | Care and treatment | Carcinoma | Analysis | Oncology, Experimental | Diagnosis | Research | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Long-term responders on olaparib maintenance in high-grade serous ovarian cancer: Clinical and molecular characterization
by Lheureux, Stephanie and Lai, Zhongwu and Dougherty, Brian A and Runswick, Sarah and Hodgson, Darren R and Timms, Kirsten M and Lanchbury, Jerry S and Kaye, Stan and Gourley, Charlie and Bowtell, David and Kohn, Elise C and Scott, Claire and Matulonis, Ursula and Panzarella, Tony and Karakasis, Katherine and Burnier, Julia V and Gilks, C. Blake and O'Connor, Mark J and Robertson, Jane D and Ledermann, Jonathan and Barrett, J. Carl and Ho, Tony W and Oza, Amit M
Clinical cancer research, ISSN 1078-0432, 08/2017, Volume 23, Issue 15, pp. 4086 - 4094
Life Sciences & Biomedicine | Oncology | Science & Technology | Piperazines - administration & dosage | Humans | Middle Aged | Ovarian Neoplasms - pathology | Neoplasm Recurrence, Local - drug therapy | Antineoplastic Agents - administration & dosage | Tumor Suppressor Protein p53 - genetics | Neoplasm Recurrence, Local - pathology | Ovarian Neoplasms - genetics | Neoplasm Grading | Antineoplastic Agents - adverse effects | Adult | Female | Ovarian Neoplasms - drug therapy | Phthalazines - administration & dosage | Antineoplastic Combined Chemotherapy Protocols | Piperazines - adverse effects | Poly(ADP-ribose) Polymerase Inhibitors - administration & dosage | BRCA1 Protein - genetics | Disease-Free Survival | Neoplasm Recurrence, Local - genetics | Aged | Mutation | BRCA2 Protein - genetics | Phthalazines - adverse effects | BRCA2 protein | Ovarian carcinoma | BRCA1 protein | p53 Protein | Homologous recombination | Homology | Breast cancer | Maintenance | Cancer therapies | Patients | Ovarian cancer | Homologous recombination repair | Chemotherapy | Experimental design | Platinum | Correlation analysis | Quality | Biomarkers | Methylation | Auditory defects | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights